Beta Bionics, Inc. (NASDAQ: BBNX) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT BETA BIONICS, INC.

Beta Bionics, Inc. (NASDAQ: BBNX)
Listen to this Section


$13.91
+0.0160 ( +0.12% ) 350.6K

Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.

Market Data


Open $13.91
Previous Close $13.89
Volume 350.6K
Market Cap $618.96M
Day Range $13.55 - $14.18
52 Week Range $8.80 - $32.71
Shares Outstanding 44.56M
Change % +0.12%
Net Change ▲ 0.0160
Insider Ownership N/A
Exchange NASDAQ
SectorIndustrials
IndustrySURGICAL & MEDICAL INSTRUMENTS & APPARATUS
IPO Year2025
CountryUnited States
UnderwriterBofA Securities, Piper Sandler, Leerink Partners, Stifel, Lake Street Capital Markets, more

Insider Ownership Transactions

Total Amount Purchased: 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Jun 04, 2025
4 Insider transactions 1 Jun 04, 2025
4 Insider transactions 1 Jun 04, 2025
4 Insider transactions 1 Jun 04, 2025
4 Insider transactions 1 Jun 04, 2025

Latest News


× Before browsing our site, please accept our cookies policy